DDX53 and Cachexia: These findings suggest that the metabolic shift towards fermentation in CM-CT26-treated myotubes could be crucially involved in the activation of cachexia, since the abolishment of CM-CT26-mediated metabolic switch, through glycolysis block or LDH inhibition, prevents the onset of the cachectic phenotype.